Alzheimer’s Disease and Related Dementias Clinical Guidelines
NEW INFORMATION ON ALZHEIMER’S TREATMENT
NIH report on blood test to detect dementia prior to symptoms released. Read the full article.
FDA grants accelerated approval for lecanemab, the second drug designed to remove plaque from the brain. Read this release from the FDA.
Preventable Risk Factors: Educating your patients. Read this article from the New York Times published July 5, 2022.
MEDICARE RESTRICTED COVERAGE OF ADUCANUMAB, OTHER DISEASE MODIFYING DRUGS
January 12, 2022 article in MedPage Today about the CDC’s decision.
ADUCANUMAB FOR ALZHEIMER’S: CONTROVERSY & COMMUNICATION ON-DEMAND WEBINAR NOW AVAILABLE
The FDA approval of AduhelmTM (aducanumab) has been a source of controversy and concern. This on-demand webinar, filmed from a live webinar hosted on July 21, 2021, will provide context and practical information for providers needing to answer questions and requests from patients and family members. Click here to access webinar.
THE ALZHEIMER’S PROJECT CLINICAL ROUNDTABLE AND GUIDELINES
Primary care physicians and providers can screen and evaluate for Alzheimer’s disease and related dementias with more confidence and ease, and access tools to manage behavioral issues. The Alzheimer’s Project Clinical Roundtable, a group of neurologists, psychiatrists, geriatricians, and geriatric psychologists, have been working since 2015 to develop tools to assist the primary care providers who will care for the vast majority of patients experiencing cognitive decline, as well as assist their family members and caregivers.
The Alzheimer’s Project is a regional initiative established by the San Diego County Board of Supervisors to address the toll of Alzheimer’s disease and related dementias on families, communities and our healthcare systems. More information on the entire Alzheimer’s Project can be found on the County website.
While the majority of patients living with dementia can be effectively managed by primary care providers, there are cases that may need further evaluation beyond the scope the primary care provider is comfortable, and appropriate referrals are then recommended. Further, should the practitioner not be comfortable with the evaluation, disclosure or disease management of a particular patient, referral to a specialist is recommended.
Guidelines Third Edition Now Available!
The Physician Guidelines Third Edition (June 2021) booklet includes screening and evaluation instruments recommended, background research and references, best practices algorithms, and resource tools for caregivers. The new edition adds information on caring for caregivers as well as assessing caregiver stress, provides updated community resources, and discusses FDA approved medications. The Guidelines booklet is comprehensive, and providers are encouraged to download/print/use those pages most relevant to their practice.
Grand Rounds, virtual and on-site education, and conferences are offered throughout the year to inform primary care providers and their staff on best practices and new resources. To schedule a presentation for your health system or practice, contact Barbara.Mandel@ChampionsFH.org.
Presentations are geared toward your specific clinical group. Topics may include:
- Screening and Evaluation of Cognitive Decline
- Updates in Research
- Genetics, Prevalence and Impact of ADRD
- Behavioral Management of ADRD
- Pharmacological Management of Behavioral Issues
- Life Planning through the Stages of Dementia
- Educating, Assessing & Supporting Caregivers
CME On-Demand Webinars
Champions for Health has partnered with The Doctors Company to offer a series of on-demand courses created by the Alzheimer’s Project Clinical Roundtable. The courses are available free of charge and are approved for AMA PRA Category 1 CreditsTM. The courses are meant to act as training tools that can be taken at your own convenience in approximately 15-minute segments. You are encouraged to revisit as needed. Courses are available to all interested healthcare professionals; check with your specific professional continuing education guidelines for eligibility to earn credits. Courses include:
- Screening for Dementia
- Evaluation and Diagnosis
- Addressing & Managing Behavioral and Environmental Signs and Symptoms
- Care Management through the Stages, Communications & Resources
- Pharmacotherapy for Dementia
- Pharmacological Management of Behavioral & Psychological Symptoms
- Q&A: What Physicians Ask About Diagnosing and Treating Dementia
- Aducanumab: Controversy & Patient Communications panel discussion
Starting the Conversation on Memory Impairment
An annual Medicare Wellness Visit is often the time that cognitive impairment can be noticed by the provider, or the patient or family member may mention concerns. See the Guidelines for Starting the Conversation, educating patients on brain health and aging, and the use of listening tools.
New Exam Room Poster to Encourage Conversation on Cognitive Decline
Download and print these 8.5 x 11 posters for your exam rooms or waiting rooms to encourage patients and family members to consider symptoms and initiate a conversation with physicians and staff.
Posters available in
Providers are encouraged to discuss clinical trials with patients during early stage disease. In San Diego County, clinical trials are currently being conducted at:
- Excell Research
- The Neurology Center
- Pacific Research Network
- Sharp Neurocognitive Research Center
- UC San Diego Alzheimer’s Disease Research Center
Providers can also find information at clinicaltrials.gov